Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS Q5117 · per 10 MG

Inj., kanjinti, 10 mg

Products billed under this code include Kanjinti, Kanjinti (Kit).

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under Q5117

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Kanjinti Amgen Inc 55513-0132-01 42 $2,682.582
Kanjinti Amgen Inc 55513-0132-21 42 $2,682.582
Kanjinti Amgen Inc 55513-0141-01 15 $958.065
Kanjinti Amgen Inc 55513-0141-21 15 $958.065
Kanjinti (Kit) Amgen Inc 55513-0164-01 42 $2,682.582

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $63.871 +$3.349 10 MG Inj., kanjinti, 10 mg v1, posted September 17, 2026
3Q26 $60.522 +$4.143 10 MG Inj., kanjinti, 10 mg v1, posted September 15, 2026
2Q26 $56.379 +$4.94 10 MG Inj., kanjinti, 10 mg v1, posted September 15, 2026
1Q26 $51.439 +$3.892 10 MG Inj., kanjinti, 10 mg v1, posted September 15, 2026
4Q25 $47.547 +$4.272 10 MG Inj., kanjinti, 10 mg v1, posted September 8, 2026
3Q25 $43.275 +$15.37 10 MG Inj., kanjinti, 10 mg v1, posted March 10, 2026
2Q25 $27.905 −$6.783 10 MG Inj., kanjinti, 10 mg v1, posted March 10, 2026
1Q25 $34.688 +$10.356 10 MG Inj., kanjinti, 10 mg v1, posted December 19, 2025
4Q24 $24.332 +$4.993 10 MG Inj., kanjinti, 10 mg v1, posted June 11, 2025
3Q24 $19.339 +$1.658 10 MG Inj., kanjinti, 10 mg v1, posted June 11, 2025
2Q24 $17.681 +$4.231 10 MG Inj., kanjinti, 10 mg v1, posted March 11, 2025
1Q24 $13.45 −$10.891 10 MG Inj., kanjinti, 10 mg v1, posted December 19, 2024
4Q23 $24.341 +$0.381 10 MG Inj., kanjinti, 10 mg v1, posted October 10, 2024
3Q23 $23.96 −$1.966 10 MG Inj., kanjinti, 10 mg v1, posted June 5, 2024
2Q23 $25.926 −$7.447 10 MG Inj., kanjinti, 10 mg v1, posted February 23, 2024
1Q23 $33.373 +$0.674 10 MG Inj., kanjinti, 10 mg v1, posted December 6, 2023
4Q22 $32.699 −$5.792 10 MG Inj., kanjinti, 10 mg v1, posted June 22, 2023
3Q22 $38.491 −$4.391 10 MG Inj., kanjinti, 10 mg v1, posted June 9, 2023
2Q22 $42.882 −$4.527 10 MG Inj., kanjinti, 10 mg v1, posted December 14, 2022
1Q22 $47.409 −$5.774 10 MG Inj., kanjinti, 10 mg v1, posted June 8, 2022
4Q21 $53.183 −$6.157 10 MG Inj., kanjinti, 10 mg v1, posted June 2, 2022
3Q21 $59.34 −$6.95 10 MG Inj., kanjinti, 10 mg v1, posted June 2, 2022
2Q21 $66.29 −$6.209 10 MG Inj., kanjinti, 10 mg v1, posted March 1, 2022
1Q21 $72.499 – 10 MG Inj., kanjinti, 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files